Imunon(IMNN) - 2024 Q1 - Quarterly Results

Exhibit 99.1 IMUNON Reports First Quarter 2024 Financial Results and Provides Business Update "Potential key value-creating milestones are upon us. We expect that this summer will be rewarding and busy as we look to improve the treatment paradigm in late-stage ovarian cancer and to offer an "mRNA-better" vaccine platform technology with excellent commercial promise," said Mr. Michael H. Tardugno, IMUNON's Executive Chairman. Dr. Lindborg, a globally recognized biostatistician, has nearly 30 years of pharmac ...